To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, ...

Citi analyst Daniel Grosslight says Hims & Hers traded up 10% yesterday after Bloomberg noted the company is now offering branded ...

2 Even with Eli Lilly’s recent self-pay alternative of a single-dose vial of tirzepatide at a 50% or greater discount, many Americans still cannot afford $5000 per year out-of-pocket.

which will help streamline access to FDA-approved Zepbound® (tirzepatide) single-dose vials for Noom’s members with an ...

Participants given tirzepatide lowered their HbA1c by a mean 0.77% more than those given a higher dulaglutide dose. More tirzepatide participants hit a weight loss threshold known for disease ...

Eli Lilly sells Zepbound vials at a discount for people not using ... alternative that contains the active ingredient called tirzepatide. It's made by a compounding pharmacy, which is a special ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling ...

which will help streamline access to FDA-approved Zepbound® (tirzepatide) single-dose vials for Noom’s members with an on-label prescription from their physician. This integration evolves Noom ...